About Evasc

Company

Evasc is a medical device company focused on novel solutions for the endovascular repair of cerebral aneurysms, to provide a much higher standard of care and rate of successful treatment outcomes than previously possible.

Evasc’s first nitinol device, the eCLIPs Bifurcation Aneurysm Remodeling System, eBRS, shows superior clinical outcomes and an excellent safety profile.  Its successor, the electrolytic eCLIPs Bifurcation device, eB, is easier to deploy and compliant with generic smaller catheters.  eCLIPs technology is protected by multiple patents and is designed to treat 95% of cerebral aneurysms, including the most challenging wide-neck bifurcations.

Board of Directors

Daguang Wang

Daguang is the Managing Director of Yonjin Capital LLC, the North America and Europe...
Read More...

Dr. David Ostrow

Dr. David Ostrow was President and CEO of Vancouver Coastal Health Authority...
Read More...

Dr. Donald Ricci

Donald Ricci, M.D. is the CEO and co-founder of Evasc, and has a 35-year history of experience...
Read More...

Dr. Martin T. Rothman

Dr. Martin Rothman was Vice President of medical affairs for coronary, structural heart and renal denervation for Medtronic...
Read More...

Management Team

Dr. Donald Ricci

CEO
Donald Ricci, M.D. is the CEO and co-founder of Evasc, and has a 35-year history of experience...
Read More...

Scott Wilson

CFO
As the CFO at Evasc, Scott Wilson manages financing rounds, investor relationships, accounting, and all financial-related activities of the company...
Read More...

Fernando Lopes

CTO
Fernando was trained as an engineer from FAAP, Brazil, and has over 35 years of electro-mechanic design experience...
Read More...

Wieger Kaptein

Director, Sales and Marketing
Wieger Kaptein has worked with a number of US-based, global medical devices leaders...
Read More...